WSHP Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-9.790.0% YoY
Profit margin0.0%COMMUNICATION SERVICES
Market cap$60.8MMicro cap

Valuation

Forward P/E
PEG ratio
P/B
8.01
P/S (TTM)
142.86
EV/EBITDA

Profitability & growth

ROE (TTM)
-947.0%
Operating margin
-42219.0%
Revenue growth YoY
-73.3%
Dividend yield
Beta
-1.16
Last earnings
Jun 4, 2026
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 2 · 32 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About WeShop Holdings Limited Class A Ordinary Shares

Wasatch Pharmaceutical, Inc., a development stage company, engages in the development of technology for the treatment of skin disorders that include acne, eczema, and psoriasis in the United States. The company is headquartered in Addison, Illinois.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
HAWK HOUSE, SAINT HELIER, JERSEY
Fiscal year end
December
Latest quarter
Jun 30, 2025
Market cap$60.8M
Shares outstanding$11.0M
52W high$250.00
52W low$4.95

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer